NurseNest
Sign InStart Free
NurseNest
AboutPricingInstitutionsBlogToolsFeaturesEvidenceExams
Sign InStart Free
RNRPNNPMedicineAlliedNew GradAdmissionsMore Exams ▼
  1. Home
  2. /Pre-nursing
  3. /Lessons
  4. /Intro Pharmacology
Back to Modules

Intro Pharmacology

Loading progress…

Save your progress across devices

Guest access stays fully free. Create a free account to keep module completion and study preferences synced on every device. No paid subscription is required for Pre-Nursing.

Create free accountSign in

Your progress · Intro Pharmacology

Pre-Nursing stays free. Progress is optional.

0% of modules

Start your first module to build momentum and unlock personalized recommendations.

Suggested next in sequence: study-strategies

Stay in Pre-Nursing

  • Practice exam for this module
  • Try the adaptive mini exam
  • Browse all modules
  • Target date & unsure pacing
  • Med math tools

Ready for exam-style prep

Paid NurseNest plans add full question banks, mocks, and pathway-scoped lessons once you are comfortable with the basics here.

  • Compare Plans
  • Browse exam lesson hubs
  • Explore NCLEX & RN/PN pathways

Set a likely route on the study planning page to personalize these links.

Focus on foundations here; we’ll keep exam prep one click away.

Pharmacology Foundations: From Drug Names to Medication Safety

A mechanistically grounded survey of pharmacology for pre-nursing students — covering drug naming, ADME kinetics, receptor pharmacology, adverse reactions, autonomic and CNS pharmacology, cardiovascular agents, ISMP high-alert medication safety, routes of administration, controlled substances, medication abbreviations, patient teaching, reconciliation, and nursing school exam traps.

Visual learning

Pharmacology safety concept map

Connect medication purpose, route, timing, expected response, adverse effects, and patient teaching.

Before

Check order + patient

During

Right dose + route

After

Monitor response

  1. 1

    Purpose

    Know why the medication is ordered and what outcome is expected.

  2. 2

    Patient factors

    Age, allergy, pregnancy, renal function, liver function, and weight can change safety.

  3. 3

    Route and timing

    Route affects onset, absorption, monitoring, and teaching.

  4. 4

    Monitor response

    Watch for therapeutic effect and adverse effects.

  5. 5

    Teach safety

    Explain what to report, what to avoid, and how to take the medication correctly.

Clinical connection

Safe medication learning begins with what the drug should do and what finding would indicate harm.

Core Concepts & Drug Names

Pharmacokinetics vs pharmacodynamics, naming systems, and suffix patterns

Pharmacokinetics (PK)

What the body does to the drug: Absorption → Distribution → Metabolism → Excretion (ADME). Describes drug concentration over time.

Pharmacodynamics (PD)

What the drug does to the body: receptor binding, mechanism of action, dose-response relationships, therapeutic and toxic effects.

Drug Naming: Three Layers

Chemical name

Full IUPAC structure — rarely used clinically

Generic name

Nonproprietary; used on NCLEX, nursing orders, drug references (e.g., metoprolol)

Brand/Trade name

Manufacturer's name, capitalized (e.g., Lopressor). Multiple brands per generic

Drug Suffix → Class Decoder (20 Suffixes)

-ololBeta-blocker
-prilACE inhibitor
-sartanARB (angiotensin receptor blocker)
-statinHMG-CoA reductase inhibitor
-dipineDihydropyridine CCB
-cillinPenicillin antibiotic
-mycinMacrolide / aminoglycoside
-azoleAntifungal or PPI
-cyclineTetracycline antibiotic
-floxacin / -oxacinFluoroquinolone
-zepamBenzodiazepine
-barbitalBarbiturate
-caineLocal anesthetic
-tidineH2 receptor blocker
-prazoleProton pump inhibitor (PPI)
-mabMonoclonal antibody
-nibTyrosine kinase inhibitor
-gliptinDPP-4 inhibitor (diabetes)
-gliflozinSGLT-2 inhibitor (diabetes)

Why Nurses Use Generic Names on NCLEX

NCLEX and clinical orders use generic names exclusively. A patient's medication list from the pharmacy may show brand names, but nursing drug references, the MAR, and NCLEX questions use generics. Knowing the suffix tells you the drug class — if you see 'metop-', you know it's a beta-blocker and can anticipate: hold for HR <60, never stop abruptly, monitor for bronchospasm.

Drug Names Check

1/3

A patient is prescribed 'losartan.' Based on its suffix, this drug belongs to which class?

Pharmacokinetics — ADME

Absorption, Distribution, Metabolism, Excretion

First-Pass Effect & Bioavailability

First-pass effect: oral drugs absorbed from the GI tract travel through the portal vein to the liver before reaching systemic circulation. The liver metabolizes a portion before it can act — this reduces bioavailability. Sublingual (nitrates), transdermal, rectal, and IV routes bypass the liver entirely, explaining why IV doses are often much lower than oral doses for the same drug.

ADME with Clinical Examples

Grapefruit + CYP3A4: A Hidden Drug Interaction

Grapefruit juice contains furanocoumarins that irreversibly inhibit intestinal CYP3A4 — the enzyme responsible for metabolizing ~50% of all drugs. Inhibiting this enzyme increases bioavailability of statins (simvastatin, atorvastatin) and dihydropyridine CCBs (amlodipine, felodipine), risking myopathy or dangerous hypotension. Even a single glass of grapefruit juice can inhibit CYP3A4 for up to 72 hours. Teach patients to avoid grapefruit with any -statin or -dipine medication.

Narrow Therapeutic Index Drugs — Monitor Closely

Narrow therapeutic index drugs require close monitoring because the toxic dose is close to the therapeutic dose. Lithium (0.6–1.2 mEq/L): toxicity with dehydration, NSAIDs, or thiazides. Digoxin (0.5–2.0 ng/mL): toxicity worsened by hypokalemia — always check K+ before giving. Warfarin (INR 2–3): dozens of food and drug interactions. Phenytoin (10–20 mcg/mL): zero-order kinetics — small dose increases cause disproportionate level rises. Aminoglycosides: peak and trough levels, nephrotoxicity and ototoxicity monitoring essential.

Pharmacodynamics — Receptors & Drug Effects

How drugs bind receptors and produce effects

Receptor Types

  • GPCRs: β-adrenergic, opioid, muscarinic — G-protein coupled, 7-TM spans
  • Ligand-gated ion channels: GABA-A (Cl⁻ influx → inhibition), nicotinic ACh receptor (Na⁺ influx → depolarization)
  • Enzyme-linked: Insulin receptor (tyrosine kinase), VEGF receptor
  • Nuclear receptors: Steroid hormones, thyroid hormone — gene transcription changes

Agonist vs Antagonist vs Partial Agonist

  • Agonist: Binds + activates receptor (mimics endogenous ligand)
  • Antagonist: Binds + blocks receptor without activating it (competitive → reversible; irreversible → covalent)
  • Partial agonist: Binds + produces submaximal activation regardless of dose. Buprenorphine: partial μ-agonist → ceiling on respiratory depression (safer in OUD treatment)

Potency vs Efficacy vs Therapeutic Index

  • Potency (EC50): Dose producing 50% max effect — lower EC50 = more potent. Potent ≠ more effective
  • Efficacy (Emax): Maximum effect achievable regardless of dose. Ceiling effect = limited Emax (partial agonists, codeine analgesic ceiling)
  • Therapeutic Index (TI): LD50 ÷ ED50 — ratio of lethal to effective dose. Narrow TI = small margin → close monitoring required
  • Competitive antagonism: Shifts dose-response curve RIGHT (↑ EC50), Emax preserved
  • Aspirin irreversible COX inhibition: Platelet effect lasts 7-10 days (platelet lifespan) — platelets cannot synthesize new COX

Drug Class → Primary Receptor Target

0/5 matched

components.interactiveLearning.terms

components.interactiveLearning.definitions

Pharmacodynamics Check

1/4

Buprenorphine has a 'ceiling effect' on respiratory depression because it is a:

Adverse Drug Reactions & Drug Interactions

Predictable, idiosyncratic, and drug-drug interactions

Type A — Predictable (70% of ADRs)

Dose-related, extension of pharmacological effect. Predictable, manageable by dose adjustment. Examples: beta-blocker bradycardia, insulin hypoglycemia, anticoagulant bleeding, diuretic hypokalemia, NSAID GI bleed. Most NCLEX adverse effects are Type A.

Type B — Idiosyncratic / Immune-Mediated

Unpredictable, not dose-related, often immunologic. Examples: penicillin anaphylaxis (IgE-mediated), clozapine agranulocytosis (weekly ANC monitoring required), halothane hepatotoxicity, Stevens-Johnson syndrome (allopurinol, sulfonamides, anticonvulsants).

Abrupt Discontinuation Syndromes — Teach Every Patient

Never stop these medications abruptly: Corticosteroids (chronic use suppresses the HPA axis — adrenal crisis with sudden cessation), Beta-blockers (rebound tachycardia, hypertension, angina, MI risk), Opioids (withdrawal syndrome: diaphoresis, piloerection, diarrhea, tachycardia), Benzodiazepines (seizures, delirium — most dangerous withdrawal). Teach every patient on long-term therapy to taper under provider guidance.

Critical Food-Drug Interactions

Grapefruit + statins/CCBs: CYP3A4 inhibition → ↑ drug levels → myopathy, hypotension
Tyramine + MAOIs: Hypertensive crisis — avoid aged cheese, cured meats, red wine
Vitamin K + warfarin: Competes for anticoagulant effect — consistent dietary K intake
Dairy + tetracycline/fluoroquinolones: Chelation → ↓ absorption 50%+
Alcohol + metronidazole: Disulfiram-like reaction: flushing, nausea, tachycardia, hypotension
Alcohol + CNS depressants: Synergistic respiratory depression

Serotonin Syndrome: Recognize and Act

Serotonin syndrome results from excess serotonergic activity, classically from combining SSRIs or SNRIs with MAOIs, triptans, linezolid, tramadol, or St. John's Wort. Classic triad: altered mental status (agitation, confusion) + neuromuscular abnormalities (clonus, hyperreflexia, tremor) + autonomic instability (hyperthermia, tachycardia, diaphoresis). Distinguish from neuroleptic malignant syndrome by time course (rapid onset, hours) and presence of clonus vs rigidity. Treatment: remove offending agent, cyproheptadine (5-HT2A antagonist), benzodiazepines, supportive cooling.

ADR & Drug Interaction Check

1/3

A patient on warfarin starts eating large amounts of leafy greens daily. You would expect their INR to:

Autonomic Pharmacology

SNS, PSNS, adrenergic and cholinergic drugs

SNS — Fight-or-Flight (NE, Epi)

  • α1: Vasoconstriction, ↑ BP, mydriasis, ↓ GI motility
  • β1: ↑ HR, ↑ contractility, ↑ renin release (kidney)
  • β2: Bronchodilation, vasodilation, uterine relaxation, ↑ glycogenolysis, K⁺ shift into cells

PSNS — Rest-and-Digest (ACh, Muscarinic)

  • ↓ HR (M2, SA node), ↑ GI motility, ↑ secretions (saliva, gastric acid)
  • Bronchoconstriction (M3), ↑ bladder detrusor tone (voiding), miosis
  • Blocked by anticholinergics: dry mouth, urinary retention, constipation, blurred vision, confusion (Beers Criteria — avoid in elderly)

Key Autonomic Drug Classes

CNS Pharmacology

Opioids, benzodiazepines, antidepressants, antipsychotics

Opioids — μ-Receptor Agonists

  • Prototype: morphine. Effects: analgesia, sedation, euphoria, respiratory depression (dose-limiting), miosis, constipation (no tolerance develops), antitussive
  • Antidote: naloxone (Narcan) — pure μ-antagonist, reverses ALL opioid effects including analgesia; short t½ → may need repeat doses or infusion for long-acting opioids
  • Codeine is a prodrug → CYP2D6 converts to morphine. Ultrarapid metabolizers: dangerously high morphine levels (black box warning in children post-tonsillectomy)
  • Buprenorphine (partial μ-agonist) + naloxone (Suboxone): OUD treatment — ceiling on respiratory depression, abuse deterrent
  • Constipation: use methylnaltrexone (peripheral μ-antagonist, does NOT cross BBB) — relieves opioid-induced constipation without reversing analgesia

Benzodiazepines — GABA-A Enhancers

  • Enhance GABA-A Cl⁻ channel opening FREQUENCY → CNS depression. NOT additive with barbiturates — synergistic
  • Uses: anxiety, insomnia, alcohol withdrawal (prevent seizures), procedural sedation, status epilepticus (diazepam, lorazepam IV)
  • Antidote: flumazenil — short acting (t½ 1h); resedation can occur with long-acting benzodiazepines
  • NEVER combine casually with opioids: black box warning for synergistic respiratory depression — risk of fatal overdose
  • Physical dependence: taper over weeks to months; abrupt cessation → seizures (can be life-threatening), worse than opioid withdrawal

SSRIs / SNRIs — Antidepressants

  • Mechanism: block serotonin reuptake transporter (SERT). SNRIs also block norepinephrine transporter (NET)
  • Onset: 2–4 weeks for therapeutic effect (receptor downregulation). First 2 weeks: suicidality risk ↑ (black box warning for patients under 25)
  • FINISH mnemonic for discontinuation syndrome: Flu-like symptoms, Insomnia, Nausea, Imbalance, Sensory disturbances (electric shock sensations), Hyperarousal. Taper slowly; paroxetine (shortest t½) highest risk
  • Serotonin syndrome risk: combining SSRI/SNRI + MAOI (absolute contraindication, 14-day washout), tramadol, triptans, linezolid, St. John's Wort

Antipsychotics — D2 Receptor Blockers

  • Typical (1st gen): haloperidol, chlorpromazine → potent D2 block → EPS: acute dystonia (hours, treat with diphenhydramine/benztropine), parkinsonism (days-weeks), akathisia (subjective restlessness), tardive dyskinesia (months-years, often irreversible)
  • Atypical (2nd gen): D2 + 5-HT2A block → lower EPS risk. Metabolic syndrome risk (weight gain, hyperglycemia, dyslipidemia): olanzapine > quetiapine > risperidone
  • Clozapine: most effective for treatment-resistant schizophrenia; agranulocytosis risk → mandatory ANC monitoring (REMS). Also: seizures (dose-related), hypersalivation, myocarditis
  • NMS (Neuroleptic Malignant Syndrome): rare but life-threatening. Fever + LEAD-PIPE rigidity + altered consciousness + autonomic instability. Distinguish from serotonin syndrome: rigidity vs clonus, slower onset (days), treat with dantrolene + bromocriptine

CNS Pharmacology Check

1/4

A patient on long-term benzodiazepines is abruptly discontinued. The most dangerous withdrawal effect is:

Cardiovascular Pharmacology

Antihypertensives, diuretics, anticoagulants, digoxin

Cardiovascular Drug Classes

Key CV Monitoring Rules

  • ACEi/ARBs: Check K+ and creatinine 1–2 weeks after starting (↑ K+, ↑ Cr expected; significant rise = stop)
  • Digoxin: Always check apical HR for 1 full minute before each dose — hold if HR <60
  • Furosemide: Monitor daily weight (gain >2 lbs/day = fluid retention), check K+ and Mg²+
  • Warfarin: Check INR before administration; review for medication and food interactions with every visit

Medication Safety — High-Alert Medications

ISMP list, LASA drugs, error prevention, 9 rights

High-Alert Medications: 5 That Can Kill Immediately

The five most dangerous high-alert medications in hospital settings: (1) Concentrated KCl — NEVER IV push; must be diluted and administered on a pump. IV bolus causes cardiac arrest within seconds. (2) Insulin — unit confusion and syringe type errors are common; always independent double-check. (3) Heparin — weight-based dosing; aPTT monitoring required. (4) Opioids — respiratory depression risk; naloxone must be available. (5) Neuromuscular blocking agents — patient must be intubated and ventilated; accidental administration to an awake patient causes conscious paralysis and terror.

LASA (Look-Alike, Sound-Alike) Medications

  • hydrOXYzine (antihistamine) vs hydrALAzine (antihypertensive)
  • vinCRIStine vs vinBLAStine (chemo — wrong one can be fatal)
  • morphine vs HYDROmorphone (hydromorphone 5–7× more potent)
  • NovoLIN vs NovoLOG (regular vs rapid-acting insulin)
  • ISMP tall-man lettering highlights differences — read EVERY letter of drug name

Do Not Use Abbreviations (TJC Official List)

  • "U" for units → misread as "0" → 10× overdose. Write "units"
  • "IU" for international units → misread as "IV" or "10". Write "units"
  • "QD"/"QOD" → misread as each other. Write "daily"/"every other day"
  • Trailing zero (1.0 mg) → misread as 10 mg. Write "1 mg" (never "1.0")
  • No leading zero (.5 mg) → misread as 5 mg. Write "0.5 mg" (always)
  • "MS"/"MSO4"/"MgSO4" → confused with each other. Write full names

The 9 Rights of Medication Administration

Right Patient (2 IDs)
Right Drug
Right Dose
Right Route
Right Time
Right Documentation
Right Reason (indication)
Right Response (monitor)
Right to Refuse

Independent Double-Check & Safe Practices

  • Independent double-check: two nurses verify drug, dose, rate, route SEPARATELY — required for insulin, heparin, chemotherapy, concentrated electrolytes
  • Never crush extended-release (XL/XR/SR/CD/LA) tablets — drug dumping causes toxicity
  • Medication reconciliation at EVERY care transition (admission, transfer, discharge) — omission errors are most common at transitions
  • PCA pumps: only the patient presses the button — never a family member or nurse (defeats the safety mechanism)
  • Concentrated KCl: must be stored separately from other IV solutions; requires pharmacist preparation; never on patient care unit floors

The #1 Most Preventable Medication Error

The most common and preventable medication error is administering a drug to the wrong patient. Always verify two patient identifiers before every administration — name AND date of birth (or medical record number). Do not rely on room number or bed label. The second most common preventable error is wrong dose due to decimal point confusion (0.1 mg vs 1.0 mg) — never use trailing zeros (1.0 mg → write 1 mg), always use leading zeros (0.1 mg, never .1 mg). The abbreviation 'U' for units has caused 10-fold overdoses (read as zero) — always write out 'units'.

Medication Safety Check

1/5

A prescriber writes 'insulin 10U subcutaneous.' The 'U' abbreviation is dangerous because:

Pharmacology Foundations — Comprehensive Quiz

1/10

A patient with low serum albumin (2.0 g/dL) is started on phenytoin (highly protein-bound). What is the expected pharmacological consequence?

Routes of Administration

How drugs reach the body

The route of administration determines how quickly a drug reaches its target, its bioavailability, and nursing safety responsibilities.

Administration Routes and Clinical Implications

Never give oral medications to unconscious patients

Administering oral medications to a patient who cannot swallow or maintain their airway risks aspiration pneumonia. If a patient is unconscious, confused, or has impaired gag reflex, hold oral medications and notify the provider immediately.

Routes Quiz

1/2

A patient is prescribed sublingual nitroglycerin for chest pain. The nurse should teach the patient to:

Medication Abbreviations and Safe Orders

What every nursing student must know

Medication order errors kill patients. Understanding safe abbreviation practices and order interpretation is a core nursing safety competency.

Common Prescription Abbreviations

PO (by mouth) · SL (sublingual) · IV (intravenous) · IM (intramuscular) · SubQ (subcutaneous) · PRN (as needed) · STAT (immediately) · QD (daily) · BID (twice daily) · TID (three times daily) · QID (four times daily) · AC (before meals) · PC (after meals) · HS (at bedtime)

Do NOT Use (ISMP/JCAHO)

U (units → write "units", looks like 0) · IU (write "international units") · QD/QOD (write "daily"/"every other day") · Trailing zero (1.0 mg → write 1 mg) · Naked decimal (.5 mg → write 0.5 mg) · MS/MSO4/MgSO4 (spell out morphine sulfate / magnesium sulfate)

When in doubt, write it out

The abbreviation 'U' has been misread as 0 (zero), resulting in 10-fold insulin overdoses. The ISMP Do Not Use list exists because these errors have caused patient deaths. Always write 'units' — never 'U'. Always use a leading zero (0.5 mg) — never a bare decimal (.5 mg). Never write a trailing zero (1 mg — not 1.0 mg).

Abbreviations Safety Quiz

1/2

A physician writes an order for 'Humulin R 10U subcutaneous.' What is the nurse's correct action?

Controlled Substances

Legal classification and nursing responsibilities

The DEA classifies controlled substances into five schedules based on medical use and abuse potential. Nurses have specific legal responsibilities for controlled substance management.

DEA Controlled Substance Schedules

Nursing controlled substance responsibilities

Count narcotics at every shift change with a witness (two nurses verify count). Document every dose removed and every dose administered. Unused portions must be wasted in the presence of a witness — both nurses sign. Report any discrepancy immediately to the charge nurse and pharmacy. Drug diversion (taking controlled substances for personal use) is a felony and results in license revocation. Never leave a controlled substance unattended.

Patient Teaching and Medication Reconciliation

Safety at every transition of care

Patient medication education and reconciliation at transitions of care are among the most important safety activities nurses perform. Errors at these points account for a significant proportion of preventable harm.

Teach-Back Method

Do NOT ask: "Do you understand?" (always answered yes). Instead ask: "Can you tell me in your own words how you'll take this medication?" or "Can you show me how to use this inhaler?" The teach-back method verifies learning. If the patient cannot demonstrate understanding, re-teach with different language or visual aids.

Key Teaching Points for Every Medication

Generic name and purpose · Dose and schedule · How to take (with/without food, avoid grapefruit) · What to monitor at home (BP, glucose, INR) · Expected vs reportable side effects · What to do if a dose is missed · Storage (light/temperature-sensitive) · Never stop without consulting provider

Medication Reconciliation

Compare ALL medications (Rx, OTC, herbals, supplements, patches, eye drops, inhalers) at EVERY transition: admission → transfer → procedure → discharge. Common errors: omission, duplication, dose discrepancy. Herbals matter: St. John's Wort induces CYP450 (↓drug levels), ginkgo + warfarin (↑bleeding).

Why reconciliation errors peak at transitions

Patients move between settings (ED → ICU → floor → home) and providers. Each transition introduces risk that a medication will be omitted, duplicated, or changed without intent. The BPMH (Best Possible Medication History) — a complete list including all Rx, OTC, and supplements — is the gold standard starting point. 50% of patients do not take medications as prescribed; non-adherence causes 125,000 deaths/year in the US.

Teaching and Reconciliation Quiz

1/2

After teaching a patient how to use a metered-dose inhaler (MDI), the nurse asks the patient to demonstrate the technique. This is an example of:

Nursing School Exam Traps in Pharmacology

What the NCLEX tests that students miss

Pharmacology questions on nursing exams test application, not memorization. These are the most common reasoning traps that cost students points.

Common NCLEX Pharmacology Traps

Exam Traps Quiz

1/3

A patient prescribed digoxin 0.125 mg daily has a serum potassium of 2.9 mEq/L. The nurse's priority action is: